ZBH Stock Chart & Fundamental Analysis

Fundamentals Charts

About ZIMMER BIOMET HOLDINGS INC

Name

ZIMMER BIOMET HOLDINGS INC

CEO

Ivan Tornos

Website

www.zimmerbiomet.com

Industry

Healthcare

Year Founded

1927

Employees

17,000

Zimmer Biomet Holdings, Inc. designs and sells musculoskeletal and dental implants, related surgical products, and care-enabling technology as a healthcare company focused on medical devices. Its business spans reconstructive joints, trauma, spine, dental, and procedure tools, and it generated $8.2 billion of revenue in FY2025.

Analyst Ratings

Consensus Recommendation

Buy0

Hold3

Sell4

Fundamentals & Financials

Revenue (TTM)

$8.4B

Net Income (TTM)

$761.3M

EPS (TTM)

$3.87

ROA (TTM)

3.35%

Current Ratio

1.73

Dividend Yield

0.27%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q1 FY2026	Q4 FY2025	Q3 FY2025
Revenue	$2,086.7M	$2,243.8M	$2,001.4M
Cost of Sales	$576,200K	$792,400K	$559,300K
Gross Profit	$1,510.5M	$1,451.4M	$1,442.1M
Operating Income	$373,200K	$287,800K	$351,300K
Net Income	$238,100K	$139,500K	$230,900K
EPS	$1.22	$0.71	$1.17

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

ZIMMER BIOMET HOLDINGS INC's Technical Indicators Summary

ZBH is trading around $87.47 and is marginally below several short- and medium-term moving averages and below the 200-day average, suggesting the bias is tilted lower. Momentum is subdued and oscillators are neutral to mildly negative, while on‑balance volume points to weaker demand. ADX shows little trend strength and volatility is moderate, and the classic pivot sits below the current price but does not offset the broader moving-average pressure. Technical takeaway: the technical picture favors a sell bias given weak volume and price below key moving averages.

Buy

0 signals

Neutral

3 signals

Sell

4 signals

Overall: Bearish57% Bearish signals

Indicator	Value	Signal	Explanation
RSI (14)	49.79	Neutral	RSI (49.79) is neutral.
Stochastic %K (14, 3, 3)	22.77	Neutral	Stochastic (22.77) is neutral.
CCI (20)	-91.27	Neutral	CCI (-91.27) is neutral.
WPR (14)	-61.02	Neutral	Williams %R (-61.02) is neutral.
Momentum (10)	0.31	Buy	Momentum (0.31) is positive.
MFI	60.11	Neutral	MFI (60.11) is neutral.
MACD Level (12, 26)	0.48	Neutral	Potential bearish reversal: MACD (0.48) crossed below signal but is still positive.
Bollinger Bands	$84.22 - $92.36	Neutral	Price is within the bands.
ATR (14)	$2.71 (3.09%)	Neutral	Moderate Volatility (3.09%).
ADX (14)	18.56	Neutral	Weak or consolidating trend (ADX < 25). ADX(18.56), +DI(18.82), -DI(25.57)
OBV	7,265,231	Sell	Bearish volume pressure: OBV is below its 20-day SMA. OBV(7,265,231), 20D-SMA-OBV(7,748,982)
Classic Pivot Point	$85.15	Buy	Price ($87.47) has broken above resistance R1 ($86.22) — bullish breakout potential.
Fibonacci Pivot Point	$85.15	Buy	Price ($87.47) has broken above resistance R1 ($86.34) — bullish breakout potential.
Simple Moving Averages	$86.01 - $91.83(5 indicators)	Sell	SMA group: 4/5 bearish, 1 bullish, 0 neutral. Price below key SMA averages.
Exponential Moving Averages	$87.60 - $91.62(5 indicators)	Sell	EMA group: 5/5 bearish, 0 bullish, 0 neutral. Price below key EMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

Closing levels show ZBH still elevated versus yesterday, after a 3.92% gap. By the final print, the sector’s 2.65% climb stood out as a meaningful tailwind. ZBH climbs on news of acquiring Pacira's iovera device, expanding non-opioid pain options and spasticity initiatives.

Trading Volume

vs S&P 500 Today

Strong Outperformance

+3.63%

52-Week Position

Lower range

28.6%

Updated: July 2, 2026 at 20:17 UTC